320 related articles for article (PubMed ID: 21171899)
1. Novel oxazine skeletons as potential antiplasmodial active ingredients: Synthesis, in vitro and in vivo biology of some oxazine entities produced via cyclization of novel chalcone intermediates.
Tiwari V; Meshram J; Ali P; Sheikh J; Tripathi U
J Enzyme Inhib Med Chem; 2011 Aug; 26(4):569-78. PubMed ID: 21171899
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and antimalarial evaluation of 1, 3, 5-trisubstituted pyrazolines.
Acharya BN; Saraswat D; Tiwari M; Shrivastava AK; Ghorpade R; Bapna S; Kaushik MP
Eur J Med Chem; 2010 Feb; 45(2):430-8. PubMed ID: 19926176
[TBL] [Abstract][Full Text] [Related]
3. Antiplasmodial activity of novel keto-enamine chalcone-chloroquine based hybrid pharmacophores.
Sashidhara KV; Kumar M; Modukuri RK; Srivastava RK; Soni A; Srivastava K; Singh SV; Saxena JK; Gauniyal HM; Puri SK
Bioorg Med Chem; 2012 May; 20(9):2971-81. PubMed ID: 22464685
[TBL] [Abstract][Full Text] [Related]
4. 4-anilinoquinoline triazines: a novel class of hybrid antimalarial agents.
Kumar A; Srivastava K; Kumar SR; Siddiqi MI; Puri SK; Sexana JK; Chauhan PM
Eur J Med Chem; 2011 Feb; 46(2):676-90. PubMed ID: 21194812
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and in vitro evaluation of new chloroquine-chalcone hybrids against chloroquine-resistant strain of Plasmodium falciparum.
Sashidhara KV; Avula SR; Palnati GR; Singh SV; Srivastava K; Puri SK; Saxena JK
Bioorg Med Chem Lett; 2012 Sep; 22(17):5455-9. PubMed ID: 22850213
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and antimalarial activity of sulfonamide chalcone derivatives.
Domínguez JN; León C; Rodrigues J; Gamboa de Domínguez N; Gut J; Rosenthal PJ
Farmaco; 2005 Apr; 60(4):307-11. PubMed ID: 15848205
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and antimalarial activity of side chain modified 4-aminoquinoline derivatives.
Solomon VR; Haq W; Srivastava K; Puri SK; Katti SB
J Med Chem; 2007 Jan; 50(2):394-8. PubMed ID: 17228883
[TBL] [Abstract][Full Text] [Related]
8. Synthesis of N1-arylidene-N2-quinolyl- and N2-acrydinylhydrazones as potent antimalarial agents active against CQ-resistant P. falciparum strains.
Gemma S; Kukreja G; Fattorusso C; Persico M; Romano MP; Altarelli M; Savini L; Campiani G; Fattorusso E; Basilico N; Taramelli D; Yardley V; Butini S
Bioorg Med Chem Lett; 2006 Oct; 16(20):5384-8. PubMed ID: 16890433
[TBL] [Abstract][Full Text] [Related]
9. In vitro efficiency of new acridyl derivatives against Plasmodium falciparum.
Guetzoyan L; Ramiandrasoa F; Dorizon H; Desprez C; Bridoux A; Rogier C; Pradines B; Perrée-Fauvet M
Bioorg Med Chem; 2007 May; 15(9):3278-89. PubMed ID: 17339112
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and evaluation of new antimalarial phenylurenyl chalcone derivatives.
Domínguez JN; León C; Rodrigues J; Gamboa de Domínguez N; Gut J; Rosenthal PJ
J Med Chem; 2005 May; 48(10):3654-8. PubMed ID: 15887974
[TBL] [Abstract][Full Text] [Related]
11. Pharmacophore based discovery of potential antimalarial agent targeting haem detoxification pathway.
Acharya BN; Saraswat D; Kaushik MP
Eur J Med Chem; 2008 Dec; 43(12):2840-52. PubMed ID: 18395298
[TBL] [Abstract][Full Text] [Related]
12. Synthesis of some cryptolepine analogues, assessment of their antimalarial and cytotoxic activities, and consideration of their antimalarial mode of action.
Onyeibor O; Croft SL; Dodson HI; Feiz-Haddad M; Kendrick H; Millington NJ; Parapini S; Phillips RM; Seville S; Shnyder SD; Taramelli D; Wright CW
J Med Chem; 2005 Apr; 48(7):2701-9. PubMed ID: 15801861
[TBL] [Abstract][Full Text] [Related]
13. Synthesis of novel 2-alkoxy-3-amino-3-arylpropan-1-ols and 5-alkoxy-4-aryl-1,3-oxazinanes with antimalarial activity.
D'hooghe M; Dekeukeleire S; Mollet K; Lategan C; Smith PJ; Chibale K; De Kimpe N
J Med Chem; 2009 Jul; 52(13):4058-62. PubMed ID: 19463002
[TBL] [Abstract][Full Text] [Related]
14. Antimalarial drugs inhibiting hemozoin (beta-hematin) formation: a mechanistic update.
Kumar S; Guha M; Choubey V; Maity P; Bandyopadhyay U
Life Sci; 2007 Feb; 80(9):813-28. PubMed ID: 17157328
[TBL] [Abstract][Full Text] [Related]
15. Synthesis of 2-[3-(7-Chloro-quinolin-4-ylamino)-alkyl]-1-(substituted phenyl)-2,3,4,9-tetrahydro-1H-beta-carbolines as a new class of antimalarial agents.
Gupta L; Srivastava K; Singh S; Puri SK; Chauhan PM
Bioorg Med Chem Lett; 2008 Jun; 18(11):3306-9. PubMed ID: 18442907
[TBL] [Abstract][Full Text] [Related]
16. Quinoline antimalarials containing a dibemethin group are active against chloroquinone-resistant Plasmodium falciparum and inhibit chloroquine transport via the P. falciparum chloroquine-resistance transporter (PfCRT).
Zishiri VK; Joshi MC; Hunter R; Chibale K; Smith PJ; Summers RL; Martin RE; Egan TJ
J Med Chem; 2011 Oct; 54(19):6956-68. PubMed ID: 21875063
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and antimalarial activity of chain substituted pivaloyloxymethyl ester analogues of Fosmidomycin and FR900098.
Kurz T; Schlüter K; Kaula U; Bergmann B; Walter RD; Geffken D
Bioorg Med Chem; 2006 Aug; 14(15):5121-35. PubMed ID: 16679022
[TBL] [Abstract][Full Text] [Related]
18. Application of multi-component reactions to antimalarial drug discovery. Part 1: Parallel synthesis and antiplasmodial activity of new 4-aminoquinoline Ugi adducts.
Musonda CC; Taylor D; Lehman J; Gut J; Rosenthal PJ; Chibale K
Bioorg Med Chem Lett; 2004 Aug; 14(15):3901-5. PubMed ID: 15225694
[TBL] [Abstract][Full Text] [Related]
19. Antimalarial activity of newly synthesized chalcone derivatives in vitro.
Yadav N; Dixit SK; Bhattacharya A; Mishra LC; Sharma M; Awasthi SK; Bhasin VK
Chem Biol Drug Des; 2012 Aug; 80(2):340-7. PubMed ID: 22429524
[TBL] [Abstract][Full Text] [Related]
20. Synthesis, in vitro antimalarial activity and cytotoxicity of novel 4-aminoquinolinyl-chalcone amides.
Smit FJ; N'da DD
Bioorg Med Chem; 2014 Feb; 22(3):1128-38. PubMed ID: 24411478
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]